Ampio Pharmaceuticals
-
Ampio Pharma receives DCGI approval to commence AP-019 Phase II study in India
The study will utilise inhaled Ampion to treat those suffering from respiratory distress due to COVID-19 Ampio Pharmaceuticals, a biopharmaceutical…
Read More »